Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
Items 101–200 of 1,000
Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea
Abraham, W. T., Jagielski, D., Oldenburg, O., Augostini, R., Krueger, S., Kolodziej, A., Gutleben, K.-J., Khayat, R., Merliss, A., Harsch, M. R., et al. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.12.013 · Cited by 133
“While effective in treating OSA, CPAP failed to improve morbidity and mortality in a large trial of CSA perhaps due to its failure to improve CSA in some patients; however, survival improved in patients whose CSA was suppressed by CPAP (14,15,16).”
BackgroundInfluentialRole of obstructive sleep apnea in cardiovascular disease
Monahan, K., & Redline, S. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834b806a · Cited by 133
Fleetham, J., Ayas, N., Bradley, D., Fitzpatrick, M., Oliver, T. K., Morrison, D., Ryan, F., Series, F., Skomro, R., Tsai, W., et al. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/506189 · Cited by 131
Self-citationClosed-Loop Control of Mechanical Ventilation: Description and Classification of Targeting Schemes
Chatburn, R. L., & Mireles‐Cabodevila, E. (2011) · Respiratory Care · doi:10.4187/respcare.00967 · Cited by 134
Arzt, M. E., Wensel, R., Montalvan, S., Schichtl, T., Schroll, S., Budweiser, S., Blumberg, F. C., Riegger, G. A. J., & Pfeifer, M. A. (2007) · CHEST Journal · doi:10.1378/chest.07-1620 · Cited by 131
Self-citationSleep Disorders in Stroke: An Update on Management
Cai, H., Wang, X., & Yang, G. (2021) · Aging and Disease · doi:10.14336/ad.2020.0707 · Cited by 147
“Bradley et al reported that CPAP treatment alleviated CSA and cardiac functions but did not improve survival in heart failure [93].”
BackgroundSleep apnea and cardiovascular risk
Floras, J. S. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.08.009 · Cited by 147
“[8] Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS, CANPAP Investigators.”
BackgroundResultInfluentialSelf-citationSleep-Disordered Breathing: Autonomic Mechanisms and Arrhythmias
Leung, R. S. T. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.06.002 · Cited by 137
“Can the patient with severe sleep apnea as measured by AHI but minimal nocturnal hypoxia be left untreated? Is severe sleep fragmentation because of repeated arousals a risk factor for sudden cardiac death? It would be tempting to simply treat all patients with sleep apnea with CPAP, but this approach has serious draw…”
BackgroundSands, S. A., Edwards, B. A., Kee, K., Turton, A., Skuza, E. M., Roebuck, T., O'Driscoll, D. M., Hamilton, G. S., Naughton, M. T., & Berger, P. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0577oc · Cited by 125
Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure
Ponikowski, P., Javaheri, S., Michalkiewicz, D., Bart, B. A., Czarnecka, D., Jastrzebski, M., Kusiak, A., Augostini, R., Jagielski, D., Witkowski, T., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr298 · Cited by 128
Sleep-Disordered Breathing and Cardiovascular Disorders
Budhiraja, R., Budhiraja, P., & Quan, S. F. (2010) · Respiratory Care · doi:10.4187/respcare.10551322 · Cited by 127
Lévy, P., Ryan, S., Oldenburg, O., & Parati, G. (2013) · European Respiratory Review · doi:10.1183/09059180.00004513 · Cited by 121
Lyons, O. D., Floras, J. S., Logan, A. G., Beanlands, R., Cantolla, J. D., Fitzpatrick, M., Fleetham, J., John Kimoff, R., Leung, R. S. T., Lorenzi Filho, G., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.790 · Cited by 121
Self-citationLehman, S., Antic, N. A., Thompson, C., CATCHESIDE, P. G., Mercer, J., & McEvoy, R. D. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8424 · Cited by 132
Non-cardiac comorbidities in chronic heart failure
Lang, C. C., & Mancini, D. M. (2007) · Heart · doi:10.1136/hrt.2005.068296 · Cited by 118
Cowie, M. R., Woehrle, H., Wegscheider, K., Angermann, C., d’Ortho, M.-P., Erdmann, E., Levy, P., Simonds, A., Somers, V. K., Zannad, F., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft051 · Cited by 123
“The CANPAP study is the only trial to date that investigated the impact of positive airway pressure treatment (CPAP) on outcomes (heart transplant-free survival) in patients with predominant CSA/ CSR.21 There was no overall survival benefit, but the results of a post-hoc analysis suggested a potential benefit in patie…”
BackgroundInfluentialRanderath, W. J., Nothofer, G., Priegnitz, C., Anduleit, N., Treml, M., Kehl, V., & Galetke, W. (2012) · CHEST Journal · doi:10.1378/chest.11-2089 · Cited by 121
von Haehling, S., Arzt, M. E., Doehner, W., Edelmann, F., Evertz, R., Ebner, N., Herrmann‐Lingen, C., Garfias‐Veitl, T., Koziolek, M. J., Noutsias, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1838 · Cited by 126
Bradley, T. D., Logan, A. G., Lorenzi‐Filho, G., Kimoff, R. J., Durán‐Cantolla, J., Arzt, M. E., Redolfi, S., Parati, G., Kasai, T., Dunlap, M. E., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00374-0 · Cited by 132
Self-citationSmith, L. A., Vennelle, M., Gardner, R. S., McDonagh, T. A., Denvir, M. A., Douglas, N. J., & Newby, D. E. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm131 · Cited by 120
“Moreover, Bradley et al.(40) demonstrated sustained improvements in LVEF and plasma norepinephrine concentrations with comparable nightly CPAP use (3.”
BackgroundInfluentialRelationship between sleep apnoea and mortality in patients with ischaemic heart failure
Yumino, D., Wang, H., Floras, J. S., Newton, G. E., Mak, S., Ruttanaumpawan, P., Parker, J. D., & Bradley, T. D. (2009) · Heart · doi:10.1136/hrt.2008.160952 · Cited by 112
Self-citationSleep-Disordered Breathing in Heart Failure
Pearse, S. G., & Cowie, M. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.492 · Cited by 119
Influence of Cardiac Resynchronisation Therapy on Different Types of Sleep Disordered Breathing
Oldenburg, O., Faber, L., Vogt, J., Dorszewski, A., Szabados, F., Horstkotte, D., & Lamp, B. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.03.009 · Cited by 110
“009 multicentre trial failed to demonstrate a positive effect on mortality in HF patients with CSA [10].”
BackgroundSleep and aging: 2. Management of sleep disorders in older people
Wolkove, N., Elkholy, O., Baltzan, M., & Palayew, M. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070335 · Cited by 91
Congestive Heart Failure: Diagnosis, Pathophysiology, Therapy, and Implications for Respiratory Care
Figueroa, M. S., & Peters, J. I. (2006) · Respiratory Care · doi:10.4187/respcare.06510403 · Cited by 144
Treatment of Sleep Apnea in Heart Failure
Arzt, M., & Bradley, T. D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1745pp · Cited by 105
Self-citationXie, J., Sert Kuniyoshi, F. H., Covassin, N., Singh, P., Gami, A. S., Chahal, C. A. A., & Somers, V. K. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007221 · Cited by 102
“Patients were considered to have central sleep apnea if the total AHI ≥15, with >50% of the breathing events of central origin.(17)”
BackgroundKasai, T. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.05.013 · Cited by 120
Sasayama, S., Izumi, T., Matsuzaki, M., Matsumori, A., Asanoi, H., Momomura, S.-I., Seino, Y., Ueshima, K., & The CHF-HOT Study Group (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1210 · Cited by 106
Adaptive servo-ventilation in heart failure patients with sleep apnea: A real world study
Hastings, P. C., Vazir, A., Meadows, G. E., Dayer, M., Poole-Wilson, P. A., McIntyre, H. F., Morrell, M. J., Cowie, M., & Simonds, A. K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.08.022 · Cited by 111
Adaptive servoventilation in diastolic heart failure and Cheyne–Stokes respiration
Bitter, T., Westerheide, N., Faber, L., Hering, D., Prinz, C., Langer, C., Horstkotte, D., & Oldenburg, O. (2009) · European Respiratory Journal · doi:10.1183/09031936.00045609 · Cited by 104
Sleep Disordered Breathing, Daytime Symptoms, and Functional Performance in Stable Heart Failure
Redeker, N. S., Muench, U., Zucker, M. J., Walsleben, J. A., Gilbert, M., Freudenberger, R. S., Chen, M., Campbell, D., Blank, L., Berkowitz, R. L., et al. (2010) · SLEEP · doi:10.1093/sleep/33.4.551 · Cited by 110
Diagnosis and treatment of sleep apnea-hypopnea syndrome
Lloberes, P., Durán‐Cantolla, J., Martínez‐García, M. Á., Marín, J. M., Ferrer, A., Corral, J., Masa, J. F., Parra, O., Alonso-Álvarez, M. L., & Téran‐Santos, J. (2011) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(11)70034-9 · Cited by 142
“Treatment consists of optimizing the treatment of the underlying disease and trying out CPAP, although the effects on survival have not been demonstrated 40,42 (weak recommendation, moderate quality of evidence).”
Xie, J., Sert Kuniyoshi, F. H., Covassin, N., Singh, P., Gami, A. S., Wang, S., Chahal, C. A. A., Wei, Y., & Somers, V. K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003162 · Cited by 94
“However, if >50% of these AHI events were central, then they were classified as central sleep apnea.(23) Severity of hypoxemia was quantified by minSaO2, and hypoxemia duration was calculated as the percentage of total sleep time associated with Figure 1.”
MethodPhrenic Nerve Stimulation to Treat Patients with Central Sleep Apnoea and Heart Failure
Costanzo, M. R., Ponikowski, P. P., Coats, A. J. S., Javaheri, S., Augostini, R. S., Goldberg, L. R., Holcomb, R. G., Kao, A. C., Khayat, R., Oldenburg, O., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1312 · Cited by 100
Latshang, T. D., Nussbaumer‐Ochsner, Y., Henn, R. M., Ulrich, S., Cascio, C. M. L., Ledergerber, B., Kohler, M., & Bloch, K. E. (2012) · JAMA · doi:10.1001/jama.2012.94847 · Cited by 101
“REM, %g 19 (14-24) 23 (18-28)c 19 (14-22)d 17 (14-23)e 17 (13-21)e .”
BackgroundHall, A. B., Ziadi, M. C., Leech, J. A., Chen, S.-Y., Burwash, I. G., Renaud, J., deKemp, R. A., Haddad, H., Mielniczuk, L. M., Yoshinaga, K., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005893 · Cited by 97
“3 hours per day.(39,40) With exclusion of the patient who was clearly noncompliant,”
BackgroundResultSelf-citationHome Mechanical Ventilation: An Overview
Simonds, A. K. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-454fr · Cited by 98
Treatment of complex sleep apnea syndrome: A retrospective comparative review
Pusalavidyasagar, S. S., Olson, E. J., Gay, P. C., & Morgenthaler, T. I. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.04.005 · Cited by 98
“Similarly, in the Canadian Continuous Positive Airway Pressure Trial for Congestive Heart Failure Patients with Central Sleep Apnea (CANPAP), there was little change in the AHI (mostly central events) between month 1 and 6 of therapy [17].”
BackgroundLyons, O. D., & Bradley, T. D. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.04.017 · Cited by 107
Self-citationFietze, I., Blau, A., Glos, M., Theres, H., Baumann, G., & Penzel, T. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.09.008 · Cited by 98
“5 h/night [12].”
BackgroundHaruki, N., Takeuchi, M., Kaku, K., Yoshitani, H., Kuwaki, H., Tamura, M., Abe, H., Okazaki, M., Tsutsumi, A., & Otsuji, Y. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr103 · Cited by 100
“Although positive airway pressure (PAP) therapies such as continuous positive airway pressure (CPAP) or bi-level PAP therapy are important therapeutic options in severe heart failure,(5,6) there are some patients who are resistant to these devices for treating CSA–CSR.(7,8) Adaptive servo-ventilation (ASV) is a novel…”
BackgroundAuto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Arzt, M., Schroll, S., Series, F., Lewis, K., Benjamin, A., Escourrou, P., Luigart, R., Kehl, V., & Pfeifer, M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00083312 · Cited by 95
“This increased mortality was not reversible in the largest randomized trial of continuous positive airway pressure (PAP) for patients with central sleep apnea (CSA) and CHF [11].”
BackgroundSelf-citationFrancis, G. S., Greenberg, B., Hsu, D. T., Jaski, B. E., Jessup, M. L., LeWinter, M. M., Pagani, F. D., Piña, I. L., Semigran, M. J., Walsh, M. N., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.014 · Cited by 100
Yeh, G., Mietus, J., Peng, C.-K., Phillips, R., Davis, R. B., Wayne, P., Goldberger, A., & Thomas, R. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.06.003 · Cited by 93
“Standard polysomnographic categorization of sleep quality shows several changes, including reduced total sleep time, reduced sleep efficiency, frequent stage shifts, increased stage 1 non-rapid eye movement (NREM) sleep, reduced to absent slow wave sleep, and a high microarousal index [1].”
BackgroundYumino, D., Kasai, T., Kimmerly, D., Amirthalingam, V., Floras, J. S., & Bradley, T. D. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0894oc · Cited by 92
Self-citationRanderath, W. J., Galetke, W., Stieglitz, S., Laumanns, C., & Schäfer, T. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.02.011 · Cited by 89
Device Therapy in Chronic Heart Failure
Fudim, M., Abraham, W. T., von Bardeleben, R. S., Lindenfeld, J. M., Ponikowski, P. P., Salah, H. M., Khan, M. S., Sievert, H., Stone, G. W., Anker, S. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.040 · Cited by 93
Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020
Akashiba, T., Inoue, Y., Uchimura, N., Ohi, M., Kasai, T., Kawana, F., Sakurai, S., Takegami, M., Tachikawa, R., Tanigawa, T., et al. (2022) · Respiratory Investigation · doi:10.1016/j.resinv.2021.08.010 · Cited by 96
Khayat, R. N., Jarjoura, D., Patt, B., Yamokoski, T., & Abraham, W. T. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.05.005 · Cited by 86
Sleep — A New Cardiovascular Frontier
Somers, V. K. (2005) · New England Journal of Medicine · doi:10.1056/nejme058229 · Cited by 86
Cheyne-Stokes Respiration in Chronic Heart Failure: Treatment With Adaptive Servoventilation Therapy
Oldenburg, O. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0689 · Cited by 103
Natural course of complex sleep apnea—a retrospective study
Kuźniar, T. J., Pusalavidyasagar, S. S., Gay, P. C., & Morgenthaler, T. I. (2007) · Sleep And Breathing · doi:10.1007/s11325-007-0140-z · Cited by 87
“In patients with CSA, CPAP leads to some but most often incomplete improvement in central apnea activity [6].”
BackgroundSleep apnoea and heart failure
Levy, P. A., Naughton, M. T., Tamisier, R., Cowie, M., & Bradley, T. D. (2021) · European Respiratory Journal · doi:10.1183/13993003.01640-2021 · Cited by 90
Self-citationLyons, O. D., Chan, C. T., Yadollahi, A., & Bradley, T. D. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2288oc · Cited by 81
Self-citationCowie, M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.12.005 · Cited by 95
Management of acute decompensated heart failure
Allen, L. A., & O'Connor, C. M. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.051620 · Cited by 93
Kasai, T., Kasagi, S., Maeno, K.-I., Dohi, T., Kawana, F., Kato, M., Naito, R., Ishiwata, S., Ohno, M., Yamaguchi, T., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2012.11.002 · Cited by 79
Sleep in Congestive Heart Failure
Sharma, B. K., Owens, R. L., & Malhotra, A. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.02.009 · Cited by 84
Detecting central sleep apnea in adult patients using WatchPAT—a multicenter validation study
Pillar, G., Berall, M. J., Berry, R. B., Etzioni, T., Shrater, N., Hwang, D., Marai, I., Litman, E., Manthena, P., Koren‐Morag, N., et al. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01904-5 · Cited by 86
Malhotra, A., & Owens, R. L. (2010) · Respiratory Care · doi:10.4187/respcare.10551168 · Cited by 99
Sleep-Disordered Breathing in Neuromuscular Disease
Aboussouan, L. S., & Mireles‐Cabodevila, E. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.023 · Cited by 83
Data maturity and follow-up in time-to-event analyses
Gebski, V., Garès, V., Gibbs, E., & Byth, K. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy013 · Cited by 84
Lavie, P. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.07.008 · Cited by 95
Sleep Disordered Breathing and Cardiovascular Diseases
Yoshihisa, A., & Takeishi, Y. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17032 · Cited by 87
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 81
Importance and management of chronic sleep apnoea in cardiology
Jaffe, L. M., Kjekshus, J., & Gottlieb, S. S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs046 · Cited by 74
(2016) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-016-0093-1 · Cited by 86
“AusgangsAHI und die linksventrikuläre Ejektionsfraktion zeigten eine signifikante Korrelation [438].”
BackgroundInfluentialBrack, T., Randerath, W. J., & Bloch, K. E. (2011) · Respiration · doi:10.1159/000331457 · Cited by 79
“The addition of -blockers that has become a mainstay of heart failure therapy in the period in between the pilot study [44] and the CANPAP trial [99] may have weakened the harmful influence of CSR and its consecutive sympathetic overstimulation on the failing heart.”
InfluentialMehra, R. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86.s1.03 · Cited by 91
The Impact of Cardiac Resynchronization Therapy on Obstructive Sleep Apnea in Heart Failure Patients
Stanchina, M. L., Ellison, K., Malhotra, A., Anderson, M. T., KIRK, M. M., Benser, M. E., Tosi, C., Carlisle, C. C., Millman, R. P., & Buxton, A. E. (2007) · CHEST Journal · doi:10.1378/chest.06-2509 · Cited by 82
Esquinas, C., Sánchez‐de‐la Torre, M., Aldomá, A., Florés, M., Martínez, M., Barceló, A., Barbé, F., & Spanish Sleep Network (2013) · Clinical Cardiology · doi:10.1002/clc.22166 · Cited by 74
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
Metra, M., Zacà, V., Parati, G., Agostoni, P., Bonadies, M., Ciccone, M. M., Dei, A., Iacoviello, M., Lagioia, R., Lombardi, C., et al. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834058d1 · Cited by 83
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure
Emdin, M., Mirizzi, G., Giannoni, A., Poletti, R., Iudice, G., Bramanti, F., & Passino, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.740 · Cited by 73
“This novel observation may at least partially explain why previous therapeutic attempts, such as continuous positive airway pressure (11) or adaptive servoventilation (12), both targeting “sleep” apnea episodes, have failed: targeting only “sleep” apnea may be insufficient in patients who manifest CAs all day.”
BackgroundJessup, M. L., Banner, N. R., Brozena, S. C., Campana, C., Costard‐Jäckle, A., Dengler, T. J., Hunt, S. A., Metra, M., Rahmel, A. O., Renlund, D. G., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.007 · Cited by 76
Sleep apnoea syndrome in 2011: current concepts and future directions
Levy, P. A., Tamisier, R., Minville, C., Launois, S. H., & Pépin, J. (2011) · European Respiratory Review · doi:10.1183/09059180.00003111 · Cited by 82
The Performance of Two Automatic Servo-Ventilation Devices in the Treatment of Central Sleep Apnea
Javaheri, S., Goetting, M. G., Khayat, R., Wylie, P. E., Goodwin, J. L., & Parthasarathy, S. (2011) · Sleep · doi:10.5665/sleep.1438 · Cited by 71
Dohi, T., Kasai, T., Narui, K., Ishiwata, S., Ohno, M., Yamaguchi, T., & Momomura, S.-I. (2008) · Circulation Journal · doi:10.1253/circj.72.1100 · Cited by 73
Kasai, T., Narui, K., Dohi, T., Takaya, H., Yanagisawa, N., Dungan, G. C., Ishiwata, S., Ohno, M., Ymaguchi, T., & Momomura, S. (2006) · Circulation Journal · doi:10.1253/circj.70.1148 · Cited by 70
Harada, D., Joho, S., Oda, Y., Hirai, T., Asanoi, H., & Inoue, H. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.12.001 · Cited by 70
Pépin, J., Chouri-Pontarollo, N., Tamisier, R., & Levy, P. A. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.10.003 · Cited by 70
Nocturnal Noninvasive Ventilation
Ozsancak, A., D’Ambrosio, C. M., & Hill, N. S. (2008) · CHEST Journal · doi:10.1378/chest.07-1527 · Cited by 76
Randerath, W. J., Galetke, W., Kenter, M., Richter, K., & Schäfer, T. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.09.017 · Cited by 68
“CPAP has been shown to reduce the figures of central disturbances by 50% [17,18].”
BackgroundContinuous Transcutaneous Submental Electrical Stimulation in Obstructive Sleep Apnea
Steier, J. S., Seymour, J. M., Rafferty, G. F., Jolley, C. J., Solomon, E., Luo, Y., Man, W. D., Polkey, M. I., & Moxham, J. (2011) · CHEST Journal · doi:10.1378/chest.10-2614 · Cited by 74
Central sleep apnoea-a clinical review.
Muza, R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2015.04.45 · Cited by 79
“The Canadian Continuous Positive Airway Pressure for Patients with CSA and Heart Failure (CANPAP) trial failed to show a survival benefit (38).”
BackgroundKee, K., & Naughton, M. T. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0869 · Cited by 67
CPAP Should Not Be Used for Central Sleep Apnea in Congestive Heart Failure Patients
Javaheri, S. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26653 · Cited by 67
Shift in sleep apnoea type in heart failure patients in the CANPAP trial
Ryan, C. M., Floras, J. S., Logan, A. G., Kimoff, R. J., Series, F., Morrison, D., Ferguson, K. A., Belenkie, I., Pfeifer, M., Fleetham, J., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00070509 · Cited by 68
Self-citationStanchina, M. L., Robinson, K., Corrao, W. M., Donat, W. E., Sands, S. A., & Malhotra, A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201410-469bc · Cited by 68
Wedewardt, J., Bitter, T., Prinz, C., Faber, L., Horstkotte, D., & Oldenburg, O. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.09.004 · Cited by 78
“A randomised outcome trial of the treatment of CSR with CPAP failed to show a significant effect on survival, but CSR was not effectively treated in many subjects [9].”
BackgroundNakamura, S., Asai, K., Kubota, Y., Murai, K., Takano, H., Tsukada, Y. T., & Shimizu, W. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0774-3 · Cited by 71
“Finally, five trials were included after a full-text analysis, thus enrolling 395 patients (196 in the PAP therapy group and 199 in the control group) in this study [4, 7, 18, 20, 21].”
MethodYoshihisa, A., Shimizu, T., Owada, T., Nakamura, Y., Iwaya, S., Yamauchi, H., Miyata, M., Hoshino, Y., Sato, T., Suzuki, S., et al. (2011) · International Heart Journal · doi:10.1536/ihj.52.218 · Cited by 67
Palliative Care and Hospice in Advanced Heart Failure
Stuart, B. (2007) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9988 · Cited by 72
Sleep disordered breathing in patients with acutely decompensated heart failure
Padeletti, M., Green, P., Mooney, A. M., Basner, R. C., & MANCINI, D. M. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.03.010 · Cited by 68
Comorbidities in Heart Failure
van der Wal, H. H., van Deursen, V. M., van der Meer, P., & Voors, A. A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_27 · Cited by 74
Relationship Between Sodium Intake and Sleep Apnea in Patients With Heart Failure
Kasai, T., Arcand, J., Allard, J. P., Mak, S. S., Azevedo, E. R., Newton, G. E., & Bradley, T. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.012 · Cited by 64
Self-citationKhayat, R., Small, R. S., Rathman, L. D., Krueger, S., Gocke, B., Clark, L., Yamokoski, L. M., & Abraham, W. T. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.04.005 · Cited by 64
Quantifying the magnitude of pharyngeal obstruction during sleep using airflow shape
Mann, D., Terrill, P. I., Azarbarzin, A., Mariani, S., Franciosini, A., Camassa, A., Georgeson, T., Marques, M., Taranto‐Montemurro, L., Messineo, L., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02262-2018 · Cited by 63
Respiratory–cardiovascular interactions
Fisher, J. P., Żera, T., & Paton, J. F. R. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91534-2.00006-0 · Cited by 71
Szalewska, D., Bellwon, J., Rynkiewicz, A., & Elkady, M. A. (2013) · Rehabilitation Research and Practice · doi:10.1155/2013/965494 · Cited by 70
“Similarly, small but significant improvements in the 6MW distance have been documented by several studies after cardiac resynchronization device implantation [28–30] and during the treatment with continuous positive airway pressure [31].”
Background
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.